Filing Details

Accession Number:
0001213900-23-028116
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-06 21:08:12
Reporting Period:
2023-04-05
Accepted Time:
2023-04-06 21:08:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822711 Pardes Biosciences Inc. PRDS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1581754 B. James Tananbaum C/O Pardes Biosciences, Inc.
2173 Salk Ave, Suite 250, Pmb#052
Carlsbad CA 92008
Yes No Yes No
1792204 Foresite Capital Fund V, L.p. 900 Larkspur Landing Circle, Suite 150
San Francisco CA 94111
No No Yes No
1792206 Foresite Capital Management V, Llc 900 Larkspur Landing Circle, Suite 150
Larkspur CA 94939
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-05 773,952 $1.50 13,583,762 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. On April 5, 2023, Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") purchased 773,952 shares of the Issuer's Common Stock at an aggregate price of approximately $1.50 per share, or $1,160,928 in the aggregate, in open market purchases. Foresite Capital Management V, LLC ("FCMVLLC") is the general partner of Capital Fund V L.P. Each of FCMVLLC and Dr. Tananbaum, in his capacity as managing member of FCMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.